Adaptive Biotechnologies Corp. Revenue and Competitors
Estimated Revenue & Valuation
- Adaptive Biotechnologies Corp.'s estimated annual revenue is currently $146.6M per year.
- Adaptive Biotechnologies Corp. received $195.0M in venture funding in May 2015.
- Adaptive Biotechnologies Corp.'s estimated revenue per employee is $166,591
- Adaptive Biotechnologies Corp.'s total funding is $406.9M.
- Adaptive Biotechnologies Corp.'s current valuation is $2.7B. (January 2022)
Employee Data
- Adaptive Biotechnologies Corp. has 880 Employees.
- Adaptive Biotechnologies Corp. grew their employee count by -9% last year.
Adaptive Biotechnologies Corp.'s People
| Name | Title | Email/Phone |
|---|---|---|
1 | CTO & CIO, SVP | Reveal Email/Phone |
2 | VP | Reveal Email/Phone |
3 | Chief Staff, Operations Management | Reveal Email/Phone |
4 | VP Finance | Reveal Email/Phone |
5 | VP Investor Relations | Reveal Email/Phone |
6 | Head Privacy | Reveal Email/Phone |
7 | VP, Molecular Product Development | Reveal Email/Phone |
8 | VP MLO (VP Molecular Laboratory Operations) | Reveal Email/Phone |
9 | VP, National Strategy and Partnerships | Reveal Email/Phone |
10 | VP Research and Development | Reveal Email/Phone |
Adaptive Biotechnologies Corp. Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $50.8M | 328 | 3% | N/A | N/A |
What Is Adaptive Biotechnologies Corp.?
We're driving groundbreaking research in cancer and other immune-mediated diseases that translates into novel clinical diagnostics and innovative therapeutics. We are at the forefront of immune-based discoveries, transforming the future state of health through our disruptive, proprietary immunosequencing technology. With strong financial footing and rapid growth, we are looking for the brightest, most passionate and collaborative innovators to join us. At Adaptive, you'll be challenged, you'll be inspired, and you'll be proud to be part of an innovative organization making a real impact on improving the quality of life globally. No matter what your role is, you'll find a diverse, team-driven, fun culture where your contributions truly count.
keywords:Consulting,Biotechnology,Enterprise Software,Healthcare,Medical Diagnostics,Pharmaceuticals
$406.9M
Total Funding
880
Number of Employees
$146.6M
Revenue (est)
-9%
Employee Growth %
$2.7B
Valuation
N/A
Accelerator
Adaptive Biotechnologies Corp. News
Adaptive biotech boasts a proprietary technology that could grant it a strong competitive edge among diagnostic stocks and is looking to address...
Adaptive Biotechnologies Corp (ADPT) stock is lower by -74.48% over the last 12 months, and the average rating from Wall Street analysts is...
The stock is Adaptive Biotechnologies (ADPT) - Get Adaptive Biotechnologies Corp. Report. The Food and Drug Administration has granted...
Adaptive Biotechnologies Corp. (Nasdaq: ADPT) and Microsoft Corp. (Nasdaq: MSFT) announced they will leverage their existing partnership mapping population-wide adaptive immune responses to diseases at scale to study COVID-19. Finding the relevant immune response signature may advance solutions ...
Other Companies in Seattle
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $285.1M | 897 | 2% | N/A |
#2 | $261.9M | 917 | N/A | N/A |
#3 | $296.2M | 932 | -1% | N/A |
#4 | $355.3M | 940 | 6% | N/A |
#5 | $75M | 972 | 5% | N/A |
Adaptive Biotechnologies Corp. Funding
| Date | Amount | Round | Lead Investors | Reference |
|---|---|---|---|---|
| 2014-04-08 | $105.0M | Undisclosed | Viking Global | Article |
| 2015-05-07 | $195.0M | F | Matrix Capital Management | Article |